ABEC Develops Single-Use Bioreactor for Emergent Manufacturing Facility

Oct 25, 2017
By Pharmaceutical Technology Editors

On Oct. 24, 2017, ABEC, a provider of engineering, equipment, and services to the biopharmaceutical manufacturing sector, announced that Emergent BioSolutions, a provider of contract manufacturing services, will equip its bulk manufacturing facility in Bayview, Baltimore, MD, with an ABEC 4,000-L custom single run (CSR) bioreactor.

The 4,000-L bioreactor will be designed specifically for Emergent’s process needs, operational requirements, and facility constraints, and will expand cell culture capacity at the Bayview site. The system can also deliver performance comparable to stainless steel systems, can be customized for different products, and is anticipated to improve cell culture productivity, process transfer, and scale-up, according to ABEC.

“ABEC’s CSR enables us to fully realize the benefits of single-use technology by improving flexibility while leveraging economies of scale,” said Scott Battist, Emergent BioSolutions’ vice president and general manager of the Bayview site, in a company press release.

Source: ABEC

native1_300x100
lorem ipsum